NanoCap ICS:ASX They run a UK Medical Billing Portal
NanoCap ICS:ASX They run a UK Medical Billing Portal. Estimated FY15 P/E 10.5, NPAT growth circa 25% based on the low end of guidance, pays a small unfranked dividend and leverage to a falling AUD/GBP FX rate. Mkt Cap $10mil. Its profitable, growing organically, dividend paying, with good free cash-flow these are statements you don't normally make about stocks down this end of the market.
Never miss an update
Enjoy this wire? Hit the ‘like’ button to let us know.
Stay up to date with my current content by
following me below and you’ll be notified every time I post a wire
I focus on ASX listed microcap and nanocap stocks which is anything from $10mil to $300mil market cap and everything in between. This truly is the under-researched part of the ASX. My hope is to bring you interesting microcap stocks and news.
2 topics
I focus on ASX listed microcap and nanocap stocks which is anything from $10mil to $300mil market cap and everything in between. This truly is the under-researched part of the ASX. My hope is to bring you interesting microcap stocks and news.
I focus on ASX listed microcap and nanocap stocks which is anything from $10mil to $300mil market cap and everything in between. This truly is the under-researched part of the ASX. My hope is to bring you interesting microcap stocks and news.
Comments
Comments
Sign In or Join Free to comment
most popular
Equities
This recently triggered market signal has never failed to predict gains
Ophir Asset Management